首页> 美国政府科技报告 >Effect of Potential Vesicant Antagonist Drugs on White Blood Cell Metabolic Activity in Human Whole Blood Exposed to 2-Chloroethyl Ethyl Sulfide
【24h】

Effect of Potential Vesicant Antagonist Drugs on White Blood Cell Metabolic Activity in Human Whole Blood Exposed to 2-Chloroethyl Ethyl Sulfide

机译:潜在的有效拮抗药物对人体全血中2-氯乙基乙基硫化物白细胞代谢活性的影响

获取原文

摘要

Mustard agent affects several pathways that involve calcium poisoning and protein degradation, but it is not clear how these pathways affect vesicant-induced toxicity. This makes it difficult to develop a good screening test to evaluate chemicals which might be used to antagonize or mitigate mustard's actions in cells. We examined here a screening test that uses live human tissue (human whole blood) and describe how monitoring the tissue after exposure to potential drugs and a vesicant can be used to estimate the overall effect of a drug or combination of drugs on vesicant exposure. Antagonizing cell death pathways of calcium poisoning (zaldaride maleate CGS9343B); C) or protein degradation (Leupeptin; L) does not satisfactorily resolve vesicant-induced toxicity. However, antagonizing pathways simultaneously might be successful. Moreover, when used with an oxidizing agent (copper-based polyoxometalate; P) that may reduce vesicant toxicity, the effectiveness of these antagonists might be improved. This approach was evaluated using a simple human whole blood (HWB) in vitro system. Prior treatment (30 min) of heparinized (40 U/mL) HWB (n=9) without (buffer vehicle) or with C (13.6 microgram/mL), L (0.5 mg/mL) or P (5.0 microgram/mL) singly (N=3) or in combination (N=4) was tested for white blood cell metabolic activity (WBCMA; Intergen ProCheck R)) post (24 h of in vitro culture) carrier (air) gas or vesicant (2-chloroethyl ethyl sulfide; CEES; 18mg at 1.5 mL/min) exposure. With carrier gas, L and/or C, significantly enhanced the measured WBCMA, while P sustained WBCMA, when compared to HWB without drug(s). This salutary, in vitro effect explained why L significantly improved or C, P, C+L, C+P or L+P sustained WBCMA with CEES, when compared to HWB without drug(s). However, when drug(s) was present in both the CEES and carrier gas conditions, the WBCMA was significantly reduced by CEES exposure.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号